Literature DB >> 1543872

Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease.

T Shigesawa1, C Sato, F Marumo.   

Abstract

Plasma glutathione levels were determined in 79 patients with various types of liver disease and 18 healthy controls in order to study their significance in the course of liver disease. Plasma was taken at the time of needle liver biopsy. A positive linear correlation was found between plasma and hepatic glutathione concentrations, as has been suggested in experimental animals. In patients with acute viral hepatitis, chronic hepatitis, non-alcoholic liver cirrhosis and alcoholic liver disease, plasma glutathione levels were significantly decreased compared with those in controls. Of importance is the fact that the plasma levels increased after recovery in patients with acute viral hepatitis and after abstinence from alcohol intake in patients with alcoholic liver disease. Determination of plasma glutathione may be valuable in the evaluation of liver disease, particularly in acute viral hepatitis and alcoholic liver disease in which the hepatic content of glutathione is suggested to be decreased. Such patients may be susceptible to oxidative stress and radical-related hepatic injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543872     DOI: 10.1111/j.1440-1746.1992.tb00926.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

2.  Sulforaphane inhibits mitochondrial permeability transition and oxidative stress.

Authors:  Tiffany Greco; Jonathan Shafer; Gary Fiskum
Journal:  Free Radic Biol Med       Date:  2011-09-21       Impact factor: 7.376

Review 3.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

4.  Lipid peroxide levels and antioxidant status in alcoholic liver disease.

Authors:  Seema Gupta; Rajesh Pandey; Ranjan Katyal; H K Aggarwal; R P Aggarwal; S K Aggarwal
Journal:  Indian J Clin Biochem       Date:  2005-01

5.  Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake.

Authors:  P Clot; M Tabone; S Aricò; E Albano
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

6.  Analgesics in patients with hepatic impairment: pharmacology and clinical implications.

Authors:  Marija Bosilkovska; Bernhard Walder; Marie Besson; Youssef Daali; Jules Desmeules
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

7.  Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis.

Authors:  Mukaddes Esrefoglu
Journal:  Hepat Mon       Date:  2012-03-28       Impact factor: 0.660

8.  Protective effect of whey proteins against nonalcoholic fatty liver in rats.

Authors:  Essam M Hamad; Soad H Taha; Abdel-Gawad I Abou Dawood; Mahmoud Z Sitohy; Mahmoud Abdel-Hamid
Journal:  Lipids Health Dis       Date:  2011-04-13       Impact factor: 3.876

Review 9.  Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.

Authors:  Thomas M Caparrotta; Daniel J Antoine; James W Dear
Journal:  Eur J Clin Pharmacol       Date:  2017-10-24       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.